Skip to main content
HARBIN GLORIA PHARMACEUTICALS Co., LTD logo

HARBIN GLORIA PHARMACEUTICALS Co., LTD — Investor Relations & Filings

Ticker · 002437 ISIN · CNE100000QG8 LEI · 300300K1ZDAXM6M73U33 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,133 across all filing types
Latest filing 2025-08-26 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002437

About HARBIN GLORIA PHARMACEUTICALS Co., LTD

https://www.gloria.cc

Harbin Gloria Pharmaceuticals Co., Ltd. focuses on the research, development, manufacturing, and commercialization of diverse pharmaceutical products. The company specializes in therapeutic areas including cardiovascular and cerebrovascular diseases, orthopedics, oncology, and metabolic disorders. Its portfolio comprises chemical drugs, biological products, and specialized injections, with key products such as Alprostadil and Deer Melon Polypeptide. The organization prioritizes technological innovation through a dedicated R&D infrastructure aimed at developing both generic and innovative medications. It maintains multiple production facilities and an extensive distribution network to supply healthcare solutions for chronic and acute conditions.

Recent filings

Filing Released Lang Actions
累积投票制实施细则（2025年8月）
Governance Information Classification · 95% confidence The document is titled as the "Implementation Rules for Cumulative Voting System" of Harbin Yuheng Pharmaceutical Co., Ltd. It details the governance procedures related to the election of directors using cumulative voting, including voting principles, election principles, and procedural rules. It references company law, governance codes, and the company's articles of association. There is no financial data, no mention of financial results, no announcement of voting results, no management changes, no legal proceedings, no capital changes, and no meeting materials. The document is a governance-related internal rule detailing the company's board election procedures and governance structure. Therefore, it fits best under Governance Information (CGR). The document length is short and it is not an announcement of a report but a substantive governance document. Confidence is high due to clear governance content and absence of other filing characteristics.
2025-08-26 Chinese
关联交易管理制度（2025年8月）
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transaction Management System'. It details the principles, scope, pricing, procedures, disclosure requirements, and governance related to related party transactions for the company Harbin Yuheng Pharmaceutical Co., Ltd. The content is a comprehensive internal policy or governance document outlining how related party transactions should be managed and disclosed in compliance with relevant laws and stock exchange rules. It does not contain financial statements, audit results, earnings data, or meeting minutes. It is not an announcement or a brief notice but a detailed governance framework document. Therefore, the document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-26 Chinese
董事会议事规则（2025年8月）
Governance Information Classification · 95% confidence The document is titled '董事会议事规则' which translates to 'Board Meeting Rules' or 'Rules of Procedure for the Board of Directors' of Harbin Yuheng Pharmaceutical Co., Ltd. It details the composition, responsibilities, meeting procedures, voting rules, and duties of the board of directors. There is no financial data, earnings information, or regulatory filings related to financial results. The content is focused on governance structure and internal rules for board operations. This matches the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is substantial and contains detailed governance rules, not just an announcement or summary. Therefore, the correct classification is CGR with high confidence.
2025-08-26 Chinese
重大资金往来管理制度（2025年8月）
Governance Information Classification · 95% confidence The document is titled '重大资金往来控制制度' which translates to 'Major Fund Transactions Control System'. It outlines internal policies and procedures for managing significant fund transactions between the company and related parties, including risk control, approval processes, and accountability mechanisms. There is no indication that this is a financial report, audit report, or regulatory filing. It is a governance-related document detailing internal rules and controls regarding fund transactions and related party dealings. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a notice or announcement but a formal internal policy document. Therefore, the best fitting category is Governance Information (CGR). The document length is 2391 characters, which is relatively short but contains substantive governance content rather than a mere announcement or certification.
2025-08-26 Chinese
内部审计制度（2025年8月）
Audit Report / Information Classification · 95% confidence The document is titled '内部审计制度' (Internal Audit System) of Harbin Yuheng Pharmaceutical Co., Ltd. It details the internal audit policies, responsibilities, procedures, and governance within the company. It references internal audit work, audit committee roles, internal control evaluation, and reporting to the board and audit committee. There is no indication that this is an audit report issued by an external auditor, nor is it a standalone audit report or certification. It is a detailed internal policy document about the internal audit system and internal control framework. It is not an annual report, earnings release, or any other financial report. It is not a regulatory filing or announcement. The content fits best under Audit Report / Information (AR) as it relates to internal audit policies and procedures, which are part of audit information but not a full annual report or external audit report. The document length and detail confirm it is a substantive report, not a brief announcement or certification. Therefore, the classification is AR with high confidence. FY 2025
2025-08-26 Chinese
敏感信息排查管理制度（2025年8月）
Governance Information Classification · 95% confidence The document is titled '敏感信息排查管理制度' which translates to 'Sensitive Information Investigation Management System'. It outlines internal company policies and procedures for managing sensitive information, including definitions, reporting obligations, and confidentiality requirements. The content focuses on governance, compliance with stock exchange rules, and internal controls to prevent insider trading and ensure proper disclosure. There are no financial statements, earnings data, or direct announcements of financial results. It is a governance-related internal policy document rather than a report or announcement of financial performance or corporate actions. Therefore, the document best fits the category of Governance Information (CGR). The document length (5393 characters) and detailed procedural content support this classification with high confidence.
2025-08-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.